Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the effect of multiple dose omeprazole on the
pharmacokinetics of boceprevir and vice versa.
Furthermore, the safety of steady state boceprevir combined with multiple dose omeprazole
will be evaluated.
Phase:
Phase 1
Details
Lead Sponsor:
Radboud University
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
HIV Protease Inhibitors Omeprazole Protease Inhibitors Proton Pump Inhibitors